It is desirable that the recent insights into APS pathogenesis, in particular the elucidation of the physiologic role of β2GPI and the identification of novel cellular pathogenic players, will soon allow opening new windows of opportunity in the management of pediatric APS. The gene discussed is APOH; the disease is autoimmune polyendocrinopathy.